Lion Point Capital, LP’s Syndax Pharmaceuticals Inc Position
Does Lion Point Capital, LP own Syndax Pharmaceuticals Inc (SNDX)? Yes — 36.0K shares worth $840,960 (+5.03% of its 13F portfolio) as of Q1 2026.
Position Value
$840,960
Q1 2026
Shares
36.0K
% of Portfolio
+5.03%
Quarters Held
12
currently held
Position History SNDX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 36.0K | $840,960 | +5.03% |
| Q4 2025 | 36.0K | $756,360 | +3.91% |
| Q3 2025 | 55.0K | $846,175 | +4.81% |
| Q2 2025 | 55.0K | $515,075 | +3.50% |
| Q1 2025 | 55.0K | $675,675 | +4.31% |
| Q4 2024 | 55.0K | $727,100 | +3.81% |
| Q3 2024 | 46.2K | $889,350 | +1.98% |
| Q2 2024 | 65.0K | $1M | +2.43% |
| Q1 2024 | 65.0K | $2M | +0.86% |
| Q4 2023 | 34.5K | $745,545 | +0.37% |
| Q3 2023 | 34.5K | $500,940 | +0.22% |
| Q2 2023 | 34.5K | $722,085 | +0.33% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of SNDX.